ABIOMED/ US0036541003 /
| 2022-12-21 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 381.19USD | - | 346,755 Turnover: 132.07 mill. |
-Bid Size: - | -Ask Size: - | 17.18 bill.USD | - | 127.01 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 87.7770 | 117.1670 | 145.0050 | 164.9310 | 197.1290 | ||||||
| Intangible Assets | - | - | - | - | 42.1500 | ||||||
| Long-Term Investments | 47.1430 | 37.5020 | 21.7180 | 207.7950 | 264.0850 | ||||||
| Fixed Assets | 223.4560 | 292.1040 | 377.1490 | 580.5990 | 706.3940 | ||||||
| Inventories | 34.9310 | 50.2040 | 80.9420 | 90.0880 | 81.0590 | ||||||
| Accounts Receivable | 54.0550 | 70.0100 | 90.8090 | 84.6500 | 97.1790 | ||||||
| Cash and Cash Equivalents | 39.0400 | 42.9750 | 121.0210 | 192.3410 | 232.7100 | ||||||
| Current Assets | 326.9580 | 494.2710 | 677.1970 | 635.8630 | 787.9650 | ||||||
| Total Assets | 550.4140 | 786.3750 | 1,054.3460 | 1,216.4620 | 1,494.3590 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 20.6200 | 23.5650 | 32.1850 | 32.7740 | 34.8420 | ||||||
| Long-term debt | 15.5390 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 16.3000 | .9000 | .8000 | .8000 | .8000 | ||||||
| Liabilities | 98.3430 | 96.8510 | 117.4560 | 150.9960 | 164.6840 | ||||||
| Share Capital | .4370 | .4440 | .4510 | .4510 | .4530 | ||||||
| Total Equity | 452.0710 | 689.5240 | 936.8900 | 1,065.4660 | 1,329.6750 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 550.4140 | 786.3750 | 1,054.3460 | 1,216.4620 | 1,494.3590 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 445.3040 | 593.7490 | 769.4320 | 840.8830 | 847.5220 | ||||||
| Depreciation (total) | 6.2020 | 11.0050 | 14.1210 | 20.4300 | 24.0970 | ||||||
| Operating Result | 90.1380 | 157.1370 | 224.8120 | 249.2190 | 229.5570 | ||||||
| Interest Income | 1.5540 | 3.6880 | 8.1660 | 12.1670 | 6.7170 | ||||||
| Income Before Taxes | 91.3430 | 160.4370 | 263.3600 | 256.8250 | 288.2200 | ||||||
| Income Taxes | 39.2270 | 48.2670 | 4.3440 | 53.8160 | 62.6950 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 52.1160 | 112.1700 | 259.0160 | 203.0090 | 225.5250 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 115.1160 | 192.5460 | 252.1970 | 314.9200 | 274.5780 | ||||||
| Cash Flow from Investing Activities | -126.3330 | -180.7620 | -116.4550 | -125.4550 | -223.3440 | ||||||
| Cash Flow from Financing | 3.8670 | -9.1370 | -55.7750 | -117.7150 | -8.0670 | ||||||
| Decrease / Increase in Cash | -9.1910 | 3.9350 | 78.0460 | 71.3200 | 40.3690 | ||||||
| Employees | 908 | 1,143 | 1,371 | 1,536 | 1,725 | ||||||
